Altimmune Inc

NASDAQ:ALT 4:00:00 PM EDT

7.20

+0.12 (+1.70%)

7:56:12 PM EDT: $7.16 -0.04 (-0.56%)

Altimmune Inc Stock, NASDAQ:ALT

910 Clopper Road, Suite 201S, Gaithersburg, Maryland 20878

United States of America

Phone: +1.240.654.1450

Number of Employees: 59

http://www.altimmune.com

Description

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.